312 related articles for article (PubMed ID: 2580900)
21. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic and morphologic profile of endogenous and pyrimidinone-activated murine NK cells.
Lotzová E; Savary CA; Lowlachi M; Murasko DM
J Immunol; 1986 Jan; 136(2):732-40. PubMed ID: 2416824
[TBL] [Abstract][Full Text] [Related]
23. Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
Flexman JP; Shellam GR
Clin Exp Immunol; 1984 Jan; 55(1):229-38. PubMed ID: 6198116
[TBL] [Abstract][Full Text] [Related]
24. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of natural killer cell activity and interferon production by manganese in young mice.
Smialowicz RJ; Riddle MM; Rogers RR; Luebke RW; Burleson GR
Immunopharmacol Immunotoxicol; 1988; 10(1):93-107. PubMed ID: 2452180
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
Hinuma S; Naruo K; Shiho O; Tsukamoto K
Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
[TBL] [Abstract][Full Text] [Related]
27. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
Oshimi K; Kano S; Takaku F; Okumura K
J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
[TBL] [Abstract][Full Text] [Related]
28. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
29. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
30. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
[TBL] [Abstract][Full Text] [Related]
31. Inhibitor cells in spleens of mice with low natural killer activity.
Blair PB; Staskawicz MO; Sam JS
J Natl Cancer Inst; 1983 Sep; 71(3):571-7. PubMed ID: 6577231
[TBL] [Abstract][Full Text] [Related]
32. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
Kalland T; Forsberg JG
J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of natural killer cell activity and tumor immunity by diacetylputrescine.
Bowlin TL; Rosenberger A; Stemerick D; Edwards ML
Cancer Res; 1990 Sep; 50(17):5460-3. PubMed ID: 2386950
[TBL] [Abstract][Full Text] [Related]
34. Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins.
Voiculescu CL; Rosu L; Rogoz S
Lymphology; 1988 Sep; 21(3):144-51. PubMed ID: 3264360
[TBL] [Abstract][Full Text] [Related]
35. Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall.
Scaringi L; Cornacchione P; Rosati E; Fettucciari K; Rossi R; Marconi P
Cell Immunol; 1994 May; 155(2):265-82. PubMed ID: 8181065
[TBL] [Abstract][Full Text] [Related]
36. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
37. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
38. Regulation of natural killer cell production in bone marrow of mice: no evidence for negative feedback control.
Bilge A; Pollack SB
Nat Immun; 1992; 11(3):156-66. PubMed ID: 1392403
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE.
Talmadge JE; Schneider M; Collins M; Phillips H; Herberman RB; Wiltrout RH
J Immunol; 1985 Aug; 135(2):1477-83. PubMed ID: 4008928
[TBL] [Abstract][Full Text] [Related]
40. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
